Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A single-center, single-arm, prospective, open-label, and comparative trial to evaluate the safety and tolerability profile of a 90-day oral L-arginine hydrochloride intervention for patients with amyotrophic lateral sclerosis.
Naito H, Nakamori M, Toko M, Hayashi Y, Tazuma T, Watanabe T, Ishihara K, Tachiyama K, Yamazaki Y, Maruyama H. Naito H, et al. Among authors: nakamori m. Sci Rep. 2025 Jan 7;15(1):1120. doi: 10.1038/s41598-024-84944-6. Sci Rep. 2025. PMID: 39774976 Free PMC article. Clinical Trial.
Early initiation of intravenous cyclophosphamide and one-year outcome in super-refractory cryptogenic-new onset refractory status epilepticus.
Yorichika Y, Neshige S, Sakahara H, Ono N, Nonaka M, Tagane Y, Watanabe T, Tachiyama K, Ishibashi H, Nakamori M, Shishido T, Aoki S, Ueno H, Yamazaki Y, Iizuka T, Maruyama H. Yorichika Y, et al. Among authors: nakamori m. Epilepsia Open. 2024 Dec 19. doi: 10.1002/epi4.13055. Online ahead of print. Epilepsia Open. 2024. PMID: 39701580 Free article.
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study.
Imamura K, Izumi Y, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Murakami T, Hanajima R, Kataoka H, Kiriyama T, Nanaura H, Sugie K, Hirayama T, Kano O, Nakamori M, Maruyama H, Haji S, Fujita K, Atsuta N, Tatebe H, Tokuda T, Takahashi N, Morinaga A, Tabuchi R, Oe M, Kobayashi M, Lobello K, Morita S, Sobue G, Takahashi R, Inoue H. Imamura K, et al. Among authors: nakamori m. BMJ Open. 2024 Oct 26;14(10):e082142. doi: 10.1136/bmjopen-2023-082142. BMJ Open. 2024. PMID: 39461864 Free PMC article.
333 results